医学信息Issue(39)：402-402,1.
枯草杆菌二联活菌肠溶胶囊联合美沙拉嗪治疗活动期溃疡性结肠炎的临床疗效分析
Clinical Effect of Medilac-S Combined with Mesalazine in the Treatment of Ulcerative Colitis
曾珺 1张姮 1吴杰1
作者信息
- 1. 武汉市中心医院消化内科，湖北 武汉 430014
- 折叠
摘要
Abstract
Objective To evaluate the clinical ef ect of Medilac-S (live combined Bacil us subtilis and Enterococcus faecium enteric-coated capsules)combined with mesalazine in the treatment of mild to moderate ulcerative colitis patients.Methods Take retrospective analysis method to analyse clinical data of 36 patients with mild to moderate ulcerative colitis using Medilac-S combined with mesalazine treatment and 36 with mesalazine method which randomly selected from January 2010 to December 2013.Divided into control group and combination group according to the dif erent method of treatment and compared.The clinical ef icacy and adverse reactions of the two groups were observed after 8 weeks of treatment.Results After 8 weeks,the total ef ective rate of clinical outcomes in the combination group and the control group was 91.67%and 63.89%;Adverse reactions occur ed 2 cases of the combination group and 12 cases in the control group.The dif erence was statistical y significant ( <0.05).Conclusion The combination of Medilac-S and mesalazine in the treatment of mild to moderate ulcerative colitis could significantly raise the clinical ef icacy and reduce the incidence of adverse reactions.关键词
溃疡性结肠炎/美沙拉嗪/枯草杆菌二联活菌肠溶胶囊Key words
Ulcerative colitis/Mesalazine/Medilac-S引用本文复制引用
曾珺,张姮,吴杰..枯草杆菌二联活菌肠溶胶囊联合美沙拉嗪治疗活动期溃疡性结肠炎的临床疗效分析[J].医学信息,2014,(39):402-402,1.
